Humira Gets Green Light For Ulcerative Colitis Treatment

An FDA Advisory Panel has recommended that the US regulatory body authorizes Humira (adalimumab) for the treatment of ulcerative colitis, a type of inflammatory bowel disease. In a 15 to 2 vote in favor of approval, a large majority of the Gastrointestinal Drugs Advisory Committee believe that Humira's benefits outweigh the risks. Although the FDA (Food and Drug Administration) does not have to abide by the Panel's recommendations, it nearly always does. Abbott Laboratories, the makers and sellers of Humira, say a final decision should be made by the FDA by the end of 2012... via Health News from Medical News Today Read More Here..